180
Participants
Start Date
March 2, 2021
Primary Completion Date
December 12, 2022
Study Completion Date
December 12, 2022
Oxytocin
intranasal administration of oxytocin (24 IU)
Vasopressin
intranasal administration of vasopressin (20 IU)
Placebo
intranasal administration of placebo
Xiaoxiao Zheng, Sichuan
University of Electronic Science and Technology of China
OTHER